Study Urges Against Lymph Node Dissection for Abemaciclib in ER-Positive Breast Cancer Dr. Garima Soni1 Sept 2024 8:30 PM ISTSweden: In breast cancer, complete axillary lymph node dissection (cALND) is associated with severe arm morbidity, research suggests. The...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Giredestrant for Breast Cancer Dr. Divya Colin7 Jan 2024 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
USFDA broadens indication for Eli Lilly's Verzenio in HR+, HER2-, Node-Positive, High Risk Early Breast Cancer Ruchika Sharma5 March 2023 4:30 PM ISTVerzenio (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 4:00 PM ISTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
FDA approves new Drug for Early Breast Cancer Dr. Kamal Kant Kohli14 Oct 2021 7:39 PM ISTThe US food and drug administration has approved a new drug abemaciclib for one type of breast cancer. FDA has s approved Abemaciclib in...
Eli Lilly gets USFDA nod to Verzenio as adjuvant therapy for breast cancer patients Ruchika Sharma14 Oct 2021 12:00 PM ISTIndianapolis: Eli Lilly and Company has recently announced that the U.S.Food and Drug Administration (USFDA) has approved the...
